Organogenesis (ORGO) Q1 2026 Earnings Transcript
Source: Motley Fool
2026-05-08 13:28:17 ET
Image source: The Motley Fool.
Thursday, May 7, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Organogenesis Holdings Inc.
NASDAQ: ORGO
ORGO Trading
0.65% G/L:
$2.6219 Last:
243,396 Volume:
$2.62 Open:
ORGO Latest News
July 09, 2026 07:30:00 am
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
July 06, 2026 04:05:00 pm
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
June 18, 2026 12:42:37 pm
Regenerative Medicine's Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 16, 2026 10:30:00 am
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
$490,515,429
46,830,580
2.02%
145
N/A
Pharmaceuticals
Healthcare
US
Canton
